The Active Compounds of Yixin Ningshen Tablet and Their Potential Action Mechanism in Treating Coronary Heart Disease- A Network Pharmacology and Proteomics Approach

Yixin Ningshen tablet is a CFDA-approved TCM formula for treating coronary heart disease (CHD) clinically. However, its active compounds and mechanism of action in treating CHD are unknown. In this study, a novel strategy with the combination of network pharmacology and proteomics was proposed to id...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Xing, Wang, Huijun, Wu, Ruoming, Shen, Xiaoyan, Ye, Guan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204378/
https://www.ncbi.nlm.nih.gov/pubmed/32419806
http://dx.doi.org/10.1155/2020/4912395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204378/
https://www.ncbi.nlm.nih.gov/pubmed/32419806
http://dx.doi.org/10.1155/2020/4912395

Ejemplares similares